Product Images Pregabalin

This is a product description for Pregabalin Capsules, with each capsule containing 200mg of the medication. The NDC number and storage instructions are provided, with a caution to keep the drug away from children. The recommended storage temperature range is given, along with instructions for excursions. This medicine is available only by prescription, and a standard package contains 30 capsules.*

This is a label for a medication package that contains a drug named "Bryant Ranck Prepack". It suggests to compare it with a drug named "Lyrica 200mg (CV) Capsule" made by "Laurus Labs Limited". It also mentions an expiration date with the format MM/YY and a NDC code. It is recommended to store the medication at room temperature and keep it away from children.*

Percent of Patients Improved: This text provides information on the percentage of patients who have improved. However, the manner in which it is presented is not entirely clear, as there are some numbers and characters that are difficult to interpret.*

The text describes a chart or table showing the percentage improvement in pain for patients. It looks like there are different values for different treatments or medications, including Pregabalin 160 mg. However, the chart or table is incomplete and some of the text is not clear, including the meaning of the values in the bottom row.*

This text appears to be a combination of numbers, medication names, and a chart showing percentages. It is not possible to generate a useful description without additional context. The text may be related to a study or analysis of patient outcomes and pain management.*

Not available.*

This appears to be a table displaying the number of patients who improved after taking either Fregabalin 100mg three times a day, Pregabalin 80mg three times a day, or a placebo. The following row shows the percentage of patients who saw improvement in pain from their baseline.*

This seems to be a chart or a table showing different doses of pregabalin, a medication used to treat neuropathic pain, and a placebo, and their effectiveness in improving pain compared to the baseline. However, the text is not completely readable, and therefore, the information is not clear.*

Not-Available. The text appears to be a chart or table with numerical values, but without context or column headers, it is impossible to determine what the data represents.*

The table indicates the percentage of subjects improved after a certain duration of treatment, specifically 16 weeks, using Pregabalin and Placebo. The improvement scale is plotted against various values ranging from 100 to 280.*